Researchers have identified a blood signature that may predict lung cancer risk more than five years before diagnosis, ...
The Lung Cancer Research Foundation announced today that a new, two-year, $300,000 research award focused on accelerating ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
Scientists have identified a 14-protein blood signature that may predict lung cancer risk more than five years before ...
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, today announced that two research awards ...
Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...
The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...
An international research team, led by Justus Liebig University Giessen (JLU), the Institute for Lung Health (ILH) in Giessen ...
As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results